Abstract
We determined the susceptibilities, by the agar dilution method, of 84 recent clinical isolates of Neisseria gonorrhoeae obtained from women with pelvic inflammatory disease in the United States to the following antimicrobial agents: penicillin, cefoxitin, cefotetan, ceftriaxone, ceftizoxime, cefixime, tetracycline, doxycycline, ciprofloxacin, ofloxacin, erythromycin, azithromycin, clindamycin, and gentamicin. Twenty-five percent of the isolates were resistant to penicillin and 20% were resistant to tetracycline. In comparison, doxycycline was more active than tetracycline and azithromycin was more active than erythromycin in vitro. Ceftriaxone, ceftizoxime, and cefixime were equally active against penicillin-susceptible isolates, but they had different in vitro activities against gonococcal isolates possessing chromosomally mediated resistance to penicillin. Overall, cefoxitin was slightly more active than cefotetan and ciprofloxacin was more active in vitro than ofloxacin, especially against N. gonorrhoeae with chromosomally mediated resistance. Criteria for the interpretation of susceptibility data for N. gonorrhoeae are not available for clindamycin or gentamicin, but for at least half of all isolates, including penicillin-susceptible isolates, at least 4 micrograms of clindamycin or gentamicin per ml was required to inhibit growth in vitro.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clendennen T. E., Echeverria P., Saengeur S., Kees E. S., Boslego J. W., Wignall F. S. Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand. Antimicrob Agents Chemother. 1992 Aug;36(8):1682–1687. doi: 10.1128/aac.36.8.1682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Handsfield H. H., Hook E. W., 3rd Ceftriaxone for treatment of uncomplicated gonorrhea: routine use of a single 125-mg dose in a sexually transmitted disease clinic. Sex Transm Dis. 1987 Oct-Dec;14(4):227–230. [PubMed] [Google Scholar]
- Handsfield H. H., McCormack W. M., Hook E. W., 3rd, Douglas J. M., Jr, Covino J. M., Verdon M. S., Reichart C. A., Ehret J. M. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group. N Engl J Med. 1991 Nov 7;325(19):1337–1341. doi: 10.1056/NEJM199111073251903. [DOI] [PubMed] [Google Scholar]
- Rice R. J., Knapp J. S. Antimicrobial susceptibilities of Neisseria gonorrhoeae strains representing five distinct resistance phenotypes. Antimicrob Agents Chemother. 1994 Jan;38(1):155–158. doi: 10.1128/aac.38.1.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schwarcz S. K., Zenilman J. M., Schnell D., Knapp J. S., Hook E. W., 3rd, Thompson S., Judson F. N., Holmes K. K. National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA. 1990 Sep 19;264(11):1413–1417. [PubMed] [Google Scholar]
- Whittington W. L., Knapp J. S. Trends in resistance of Neisseria gonorrhoeae to antimicrobial agents in the United States. Sex Transm Dis. 1988 Oct-Dec;15(4):202–210. doi: 10.1097/00007435-198810000-00006. [DOI] [PubMed] [Google Scholar]
- Zenilman J. M., Whittington W. L., Frazier D., Rice R. J., Knapp J. S. Penicillinase-producing Neisseria gonorrhoeae in Dade County, Florida: phenotypic characterization of isolates from 1983, 1984, and 1986. Sex Transm Dis. 1988 Jul-Sep;15(3):158–163. doi: 10.1097/00007435-198807000-00010. [DOI] [PubMed] [Google Scholar]